These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27137208)

  • 1. Immune thrombocytopenia in ulcerative colitis.
    Casella G; Antonelli E; Villanacci V; Salemme M; Di Bella C; Baldini V; Bassotti G
    Tech Coloproctol; 2016 Jul; 20(7):499-500. PubMed ID: 27137208
    [No Abstract]   [Full Text] [Related]  

  • 2. Infliximab Efficacy and Safety in an Ulcerative Colitis Patient with Systemic Lupus Erythematosus.
    Ben-Horin S; Ungar B; Eliakim R; Langevitz P
    J Crohns Colitis; 2016 Jun; 10(6):752-3. PubMed ID: 26826571
    [No Abstract]   [Full Text] [Related]  

  • 3. Lack of efficacy of infliximab in the treatment of primary sclerosing cholangitis in inflammatory bowel diseases in childhood.
    Cardile S; Candusso M; Papadatou B; Bracci F; Knafelz D; Torre G
    Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):736. PubMed ID: 28441268
    [No Abstract]   [Full Text] [Related]  

  • 4. Intensification of maintenance therapy with infliximab in ulcerative colitis.
    Casellas F
    Rev Esp Enferm Dig; 2015 Sep; 107(9):525-6. PubMed ID: 26334457
    [No Abstract]   [Full Text] [Related]  

  • 5. Unilateral and irreversible optic neuropathy associated to infliximab treatment: 3-year follow-up.
    Garcia-Medina JJ; Pastor-Grau A; del-Rio-Vellosillo M; Zanon-Moreno V; Pinazo-Duran MD
    Scand J Gastroenterol; 2016; 51(6):765-6. PubMed ID: 26727952
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe Henoch-Schönlein purpura complicating infliximab therapy for ulcerative colitis.
    Laresche C; Locatelli F; Biver-Dalle C; Nachury M; Heyd B; Koch S; Aubin F
    Cutis; 2017 Jan; 99(1):E20-E22. PubMed ID: 28207014
    [No Abstract]   [Full Text] [Related]  

  • 7. A Rare But Devastating Dermatologic Manifestation of Ulcerative Colitis.
    Kuftinec GN; Lim JE; Yarur AJ
    Gastroenterology; 2023 May; 164(6):883-886. PubMed ID: 36336001
    [No Abstract]   [Full Text] [Related]  

  • 8. Infliximab-induced thrombocytopenia in a patient with ulcerative colitis.
    Matsumoto S; Mashima H
    Int J Colorectal Dis; 2016 Apr; 31(4):921-2. PubMed ID: 26149944
    [No Abstract]   [Full Text] [Related]  

  • 9. Multifocal Motor Neuropathy Associated with Infliximab.
    Rowan CR; Tubridy N; Cullen G
    J Crohns Colitis; 2015 Dec; 9(12):1174-5. PubMed ID: 26223843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of controlling inflammatory activity in the colon on the response to infliximab of autoimmune haemolytic anaemia associated with ulcerative colitis.
    Leo-Carnerero E; Araujo-Míguez A; Trigo-Salado C; De-la-Cruz-Ramírez MD; Herrera-Justiniano JM; Márquez-Galán JL
    Rev Esp Enferm Dig; 2014 Apr; 106(4):295-6. PubMed ID: 25075665
    [No Abstract]   [Full Text] [Related]  

  • 11. Irreversible optic neuritis after infliximab treatment in a patient with ulcerative colitis.
    Clemmensen K; Akrawi N; Stawowy M
    Scand J Gastroenterol; 2015; 50(12):1508-11. PubMed ID: 26133362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolution of immune thrombocytopenic purpura after colectomy for ulcerative colitis.
    Varderili E; Sariçam T; Aslan V; Gülbaş Z
    Turk J Gastroenterol; 2003 Dec; 14(4):270-2. PubMed ID: 15048604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further evidence that exacerbation of ulcerative colitis causes the onset of immune thrombocytopenia: a clinical case.
    Kodaira M; Hanai H; Kajimura M; Futami H; Maruyama Y; Sato Y; Arai H; Kaneko E
    Am J Gastroenterol; 1999 May; 94(5):1408-10. PubMed ID: 10235229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recurrent auto-immune thrombopenic purpura during a severe attack of ulcerative colitis].
    Vaucher C; Bideau K; Nousbaum JB; Sensebé L; Février L; Robaszkiewicz M; Gouérou H
    Gastroenterol Clin Biol; 1998 Dec; 22(12):1114-6. PubMed ID: 10051993
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune thrombocytopenic purpura in patients with ulcerative colitis.
    Mizuta Y; Isomoto H; Kadokawa Y; Akazawa Y; Chin S; Kanazawa Y; Takeshima F; Omagari K; Murase K; Sawai T; Nakagoe T; Murata I; Kohno S
    J Gastroenterol; 2003; 38(9):884-90. PubMed ID: 14564634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory bowel disease and immune thrombocytopenic purpura: is there a correlation?
    Zlatanic J; Korelitz BI; Wisch N; Kim P; Ammirati M; Schwarz S; Gruenstein S; Lipsey L
    Am J Gastroenterol; 1997 Dec; 92(12):2285-8. PubMed ID: 9399771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Unusual Skin Manifestation in a Patient With Ulcerative Colitis.
    Dawkins YM; Kanigsberg N; Murthy S
    Clin Gastroenterol Hepatol; 2016 Jan; 14(1):A35-6. PubMed ID: 26291668
    [No Abstract]   [Full Text] [Related]  

  • 18. Lewis-Sumner syndrome associated with infliximab therapy in ulcerative colitis.
    Cirillo G; Todisco V; Tedeschi G
    Neurol Sci; 2016 Jun; 37(6):1005-8. PubMed ID: 26838522
    [No Abstract]   [Full Text] [Related]  

  • 19. Sacroileitis and peripheral arthropathy associated with ulcerative colitis: effect of infliximab on both articular and intestinal symptoms.
    Lupascu A; Armuzzi A; De Pascalis B; Carloni E; Lauritano EC; Gasbarrini A; Pola P; Gasbarrini A
    Dig Liver Dis; 2004 Jun; 36(6):423-5. PubMed ID: 15248384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Takayasu arteritis developing during treatment of ulcerative colitis with infliximab.
    Horai Y; Satoru O; Lapalme-Remis S; Sumiyoshi R; Nakashima Y; Suzuki T; Okada A; Kawashiri SY; Ichinose K; Tamai M; Yamasaki S; Nakamura H; Takeshima F; Origuchi T; Kawakami A
    Mod Rheumatol; 2013 May; 23(3):572-6. PubMed ID: 22718488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.